
Noloss ET 250mg/250mg Tablet
Marketer
Surge Biotech Pvt Ltd
Salt Composition
Tranexamic Acid (250mg) + Ethamsylate (250mg)
Overview Noloss ET 250mg/250mg Tablet
Tranexamic acid and ethamsylate 250mg/250mg tablets are prescribed to manage heavy menstrual bleeding. This dual-action medication inhibits clot breakdown, thus controlling excessive blood loss, and enhances platelet aggregation for improved clotting. Dosage timing is flexible—with or without food—but consistency (same time daily) is recommended. Continue treatment as directed by your physician. Missed doses should be taken promptly; complete the prescribed course regardless of symptom improvement. Abrupt cessation requires medical consultation. Common side effects encompass nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is advised to mitigate dehydration. If bleeding patterns remain unchanged after three consecutive menstrual cycles, seek medical attention. Prior to initiating treatment, disclose any kidney issues, vaginal bleeding disorders, pregnancy, or breastfeeding to your doctor. Full disclosure of all other medications is crucial. Regular eye examinations may be requested during treatment.
Primary Ingredients of Noloss ET 250mg/250mg Tablet
No text provided to rephrase.
Uses of Noloss ET 250mg/250mg Tablet
Profound menstrual hemorrhage
Major Benefits of Noloss ET 250mg/250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Noloss ET 250mg/250mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Noloss ET 250mg/250mg Tablet:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use Noloss ET 250mg/250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Noloss ET 250mg/250mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Noloss ET 250mg/250mg Tablet works:
Noloss ET 250mg/250mg tablets contain Tranexamic Acid and Ethamsylate, two medications that work synergistically to manage bleeding. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots by inhibiting their breakdown. Ethamsylate, a hemostatic drug, enhances platelet aggregation and clot formation, thereby reducing bleeding, particularly from small capillaries.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Noloss ET 250mg/250mg tablets and alcohol can induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Noloss ET 250mg/250mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Noloss ET 250mg/250mg Tablet with breastfeeding are lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Noloss ET 250mg/250mg Tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Noloss ET 250mg/250mg Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Noloss ET 250mg/250mg tablets in patients with hepatic impairment is likely safe, with existing evidence indicating dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Noloss ET 250mg/250mg Tablet :
Should you forget a Noloss ET 250mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Noloss ET 250mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
